JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (JSP.BK)
THB 2.2
(5.77%)
THB 2.2
(5.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 28.13 Million | -5.15 Million | 51.72 Million | 45.98 Million | 54.87 Million | -3.66 Million |
| Net Income | -1.26 Million | -17.48 Million | 29.69 Million | 31.08 Million | 23.56 Million | 12.39 Million |
| Depreciation & Amortization | 46.71 Million | 26.04 Million | 22.22 Million | 22.08 Million | 15.94 Million | 13.14 Million |
| Deferred income taxes | 9.31 Million | -3.95 Million | 7.73 Million | 8.59 Million | 6.52 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.43 Million | -22.76 Million | -9.99 Million | -27.58 Million | 2.59 Million | -33.6 Million |
| Other non-cash items | 61.07 Million | 13 Million | 9.65 Million | 11.03 Million | 12.26 Million | 55.64 Million |
| Investing Cash Flow | -203.62 Million | -469.21 Million | -58.26 Million | -1.53 Million | -24.57 Million | -48.54 Million |
| Investments in PPE | -173.56 Million | -290.36 Million | -37.08 Million | -7.83 Million | -20.9 Million | -53.48 Million |
| Acquisitions | -258.54 Million | 756.58 Thousand | 5.61 Million | 105.27 Thousand | 1.99 Million | 737.41 Thousand |
| Investment purchases | -369.5 Million | -749.5 Million | -27 Million | - | - | - |
| Sales/Maturities of investments | 578.82 Million | 568.85 Million | -5.61 Million | - | - | - |
| Other Investing Activities | 19.16 Million | 1.03 Million | 5.81 Million | 6.19 Million | -5.67 Million | 4.2 Million |
| Financing Cash Flow | 95.94 Million | -53.73 Million | 629.95 Million | -44.09 Million | -30.38 Million | 49.37 Million |
| Debt repayment | -67.43 Million | -40.72 Million | -142.62 Million | -57.04 Million | -125.27 Million | -19.37 Million |
| Dividends payments | -119.00 | -6 Million | -28 Million | -32.17 Million | - | - |
| Common Stock Repurchased | -100.12 Thousand | - | - | - | - | - |
| Common Stock Issuance | 48.88 Million | - | 759.84 Million | 32.05 Million | 30 Million | 30 Million |
| Other Financing Activities | 114.59 Million | -7.01 Million | 40.73 Million | 13.06 Million | 64.88 Million | 16.19 Million |
| Accounts receivables | 32.9 Million | -40.12 Million | 12.35 Million | 11.22 Million | 2.6 Million | -19.47 Million |
| Accounts payables | -21.39 Million | 5.88 Million | 10.38 Million | 432.67 Thousand | 633.91 Thousand | -13.13 Million |
| Inventory | 6.97 Million | 1.39 Million | -33.51 Million | -41.07 Million | -4.77 Million | 7.65 Million |
| Other working capital | -21.92 Million | 10.07 Million | 786.12 Thousand | 1.82 Million | 4.13 Million | -8.64 Million |
| Cash at beginning of period | 100.19 Million | 623.9 Million | 492.44 Thousand | 136.65 Thousand | 220.05 Thousand | 3.05 Million |
| Cash at end of period | 20.65 Million | 95.8 Million | 623.9 Million | 492.44 Thousand | 136.65 Thousand | 220.05 Thousand |
| Capital Expenditure | -173.56 Million | -290.36 Million | -37.08 Million | -7.83 Million | -20.9 Million | -53.48 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -79.54 Million | -528.1 Million | 623.41 Million | 355.78 Thousand | -83.39 Thousand | -2.83 Million |
| Free Cash Flow | -145.43 Million | -295.52 Million | 14.63 Million | 38.14 Million | 33.97 Million | -57.15 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 14.17 Million | -2.46 Million | 6.69 Million | -1.26 Million | 35.28 Million | -12.79 Million |
| Depreciation & Amortization | 14.78 Million | 14.74 Million | 14.09 Million | 46.71 Million | 12.82 Million | 10.71 Million |
| Deferred income taxes | 3.92 Million | -587 Thousand | 1.88 Million | 9.31 Million | 10.48 Million | -3.4 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -15.7 Million | 19.58 Million | -3.28 Million | -3.43 Million | 1.67 Million | -9.88 Million |
| Other non-cash items | 43.37 Million | 22.55 Million | 19.9 Million | 61.07 Million | 3.64 Million | 2.24 Million |
| Investing Cash Flow | -7.97 Million | -16.56 Million | -30.4 Million | -203.62 Million | -72.35 Million | -33.39 Million |
| Investments in PPE | -7.97 Million | -16.62 Million | -36.15 Million | -173.56 Million | -24.66 Million | -25.94 Million |
| Acquisitions | - | 59 Thousand | 428.00 | -258.54 Million | -200 Million | 81 Thousand |
| Investment purchases | - | - | - | -369.5 Million | 120 Thousand | -178 Million |
| Sales/Maturities of investments | - | - | 5.75 Million | 578.82 Million | 134.1 Million | 228.86 Million |
| Other Investing Activities | 94 Thousand | 36.99 Thousand | -396.00 | 19.16 Million | 18.09 Million | -58.39 Million |
| Financing Cash Flow | -13.49 Million | 3.14 Million | 3.64 Million | 95.94 Million | 35.34 Million | -16.11 Million |
| Debt repayment | -10.01 Million | -6.24 Million | -6.12 Million | -67.43 Million | -8.32 Million | -13.46 Million |
| Dividends payments | - | - | -119.00 | -119.00 | -10.99 Million | - |
| Common Stock Repurchased | - | - | -38.12 Thousand | -100.12 Thousand | -62 Thousand | - |
| Common Stock Issuance | - | - | 250.00 | 48.88 Million | 162 Thousand | - |
| Other Financing Activities | -3.48 Million | -21.98 Million | 9.81 Million | 114.59 Million | 54.57 Million | 7.34 Million |
| Accounts receivables | -11.15 Million | 2.65 Million | 11.41 Million | 32.9 Million | 762 Thousand | 18.19 Million |
| Accounts payables | 4.86 Million | 13.42 Million | -8.53 Million | -21.39 Million | -15.62 Million | 7.18 Million |
| Inventory | -1.18 Million | -13.95 Million | -1.74 Million | 6.97 Million | 25.21 Million | -14.55 Million |
| Other working capital | -8.22 Million | 17.45 Million | -4.41 Million | -21.92 Million | -8.67 Million | -20.7 Million |
| Cash at beginning of period | 34.29 Million | 20.65 Million | 37.05 Million | 100.19 Million | 60.08 Million | 115.07 Million |
| Cash at end of period | 32.41 Million | 34.29 Million | 20.65 Million | 20.65 Million | 37.05 Million | 60.08 Million |
| Capital Expenditure | -7.97 Million | -16.62 Million | -36.15 Million | -173.56 Million | -24.66 Million | -25.94 Million |
| Effect of forex changes on cash | - | - | -191.00 | - | 4.39 Million | - |
| Net cash flow / Change in cash | -1.88 Million | 13.64 Million | -16.4 Million | -79.54 Million | -23.02 Million | -54.99 Million |
| Free Cash Flow | 11.61 Million | 10.44 Million | -25.8 Million | -145.43 Million | -15.07 Million | -31.42 Million |
ETC
ALDBL
VINCIT
NC5A
300611
603179